U.S. flag An official website of the United States government
  1. Home
  2. Vaccines, Blood & Biologics
  3. DENGVAXIA
  1. Vaccines, Blood & Biologics

STN: 125682
Proper Name: Dengue Tetravalent Vaccine, Live
Tradename: DENGVAXIA
Manufacturer: Sanofi Pasteur Inc.
Indication:

  • Indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4. DENGVAXIA is approved for use in individuals 9 through 16 years of age with laboratory-confirmed previous dengue infection and living in endemic areas.

Product Information

Supporting Documents